Vertaling van "health and consumer protection directorate-general " (Frans → Nederlands) :

vCJD transmission by blood », European Commission Health and Consumer Protection Directorate-General, October 2004, 13 pages. d) Enquête EC Public Health and Risk Assessment « Precautionary measures against
vCJD transmission by blood », European Commission Health and Consumer Protection Directorate-General, October 2004, 13 bladzijden. d) Enquête EC Public Health and Risk Assessment « Precautionary measures against

WNV transmission by blood », European Commission Health and Consumer Protection Directorate-General, October 2004, 3 pages.
WNV transmission by blood », European Commission Health and Consumer Protection Directorate-General, October 2004, 3 bladzijden.

vCJD transmission by blood », European Commission Health and Consumer Protection Directorate-General, Octobre 2004, 13 pages. d) Communiqué de presse «Durcissement des critères applicables aux dons de sang »,
vCJD transmission by blood », European Commission Health and Consumer Protection Directorate-General, October 2004, 13 bladzijden. d) Communiqué de presse «Durcissement des critères applicables aux dons de sang »,

o Report on tasks for scientific cooperation (SCOOP), report of experts participating in tasks 3.2.11, DG Health and Consumer Protection, Mars 2004
o Report on tasks for scientific cooperation (SCOOP), report of experts participating in tasks 3.2.11, DG Health and Consumer Protection, Maart 2004

Directorate General for Health & Consumers - Consumer affairs current consultations - Commission européenne
Directorate General for Health & Consumers - Consumer affairs current consultations - Europese Commissie

Direction générale ‘Santé et protection des consommateurs’ (DG SANCO) - Commission européenne [http ...]
Directoraat-Generaal Gezondheids- en consumentenbescherming (DG SANCO) - Europese Commissie

Simplifiant la structure de sa haute direction, Novartis réduit la taille du Comité de direction de douze à neuf membres. Il sera composé de: Joe Jimenez, Directeur général, D r Mark Fishman, , Directeur Monde NIBR (The Novartis Institute for BioMedical Research); David Epstein, Directeur de la division Pharmaceuticals, Jeff George, Directeur de la division Generics, George Gunn, Directeur de la division Consumer Health, D r Andrin Oswald, Directeur de la division Vaccins et Diagnostic; Jon Symonds, Directeur finanier, Thomas Werlen, General Counsel et Jürgen Brokatzky-Geiger, Directeur Monde des Ressources Humaines.
9. They will be Joe Jimenez, CEO; Mark Fishman, M.D., Global Head of NIBR (The Novartis Institute for BioMedical Research); David Epstein, Division Head Pharmaceuticals; Jeff George, Division Head Generics; George Gunn, Division Head Consumer Health: Andrin Oswald, M.D., Division Head Vaccines and Diagnostics; Jon Symonds, CFO; Thomas Werlen, General Counsel; and Jürgen Brokatzky-Geiger, Global Head Human Resources.

En Belgique, Novartis compte plusieurs divisions: Novartis Pharma (comprenant 3 business units: General Medicines, Vaccins et Oncologie), Sandoz, Novartis Consumer Health OTC et Alcon Eye Care.
In België bestaat Novartis uit meerdere divisies: Novartis Pharma (bestaande uit 3 business units: General Medicines, Vaccins en Oncologie), Sandoz, Novartis Consumer Health en Alcon Eye Care.

En Belgique, Novartis est composée de plusieurs divisions: Novartis Pharma (comprenant 2 business units: General Medicines et Oncologie), Sandoz, Novartis Consumer Health OTC et CIBA VISION.
In België telt Novartis volgende divisies: Novartis Pharma (bestaande uit 2 business units: General Medicines en Oncology), Sandoz, Novartis Consumer Health OTC en CIBA VISION.